why choose us

Clinical Trials Search

Showing 20,560 of 132,963 result(s)
Brachial Plexus Block vs. General Anesthesia for Anesthesia Anxiety Before Orthopedic Upper Extremity Surgery

Status: Completed

Condition: Orthopedic Disorder
Anxiety
Upper Extremity Injury
Surgery

Interventions: Interventional

Date: 2022-07-25

ArtemiCoffee in Patients With Rising PSA

Status: Completed

Condition: Prostate Cancer

Interventions: 3 cups of Artemisia annua (Aa) coffee per day (1350mg) for 24 weeks.

Date: 2022-07-25

Blood Biomarkers in Pediatric Kidney Transplant Recipients

Status: Completed

Condition: Rejection of Kidney Allograft

Interventions: Includes blood draws and data collection only

Date: 2022-07-25

Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

Status: Completed

Condition: Atrial Fibrillation

Interventions: Cardiac catheter ablation for recurrent AF after previous ablation (catheter or surgical).

Date: 2022-07-25

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

Status: Completed

Condition: Diabetes Mellitus, Type 1

Interventions: GLP1-RA

Date: 2022-07-25

A Personalized Voice Restoration Device for Patients With Laryngectomy

Status: NOT_YET_RECRUITING

Condition: Dysphonia

Interventions: Surface ElectroMyoGraphy (SEMG) is a non-invasive technique for measuring muscle electrical activity that occurs during muscle contraction and relaxat

Date: 2022-07-25

ClientBot: A Conversational Agent That Supports Skills Practice and Feedback for Motivational Interviewing

Status: Completed

Condition: Motivational Interviewing

Interventions: ClientBot is an AI-based simulated client that supports skills improvement for providers learning and using Motivational Interviewing

Date: 2022-07-25

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Status: Completed

Condition: Dyslipidemias

Interventions: Bempedoic Acid is an oral first-in-class small molecular adenosine triphosphate (ATP)-citrate lyase (ACL) inhibitor which lowers LDL-C by inhibition o

Date: 2022-07-25

Patient Observational Pain and Activity Survey (POPAS) Study Using RS-4i Sequential Stimulator With Intersperse Technology in Axial Spine and Peripheral Joint Pain

Status: Completed

Condition: Osteoarthritis

Interventions: RS-4i Plus in an FDA-regulated prescription TENS medical device that outputs and INF signal and a NMES signal and Intersperse signal, which combines I

Date: 2022-07-25

Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis

Status: Completed

Condition: Ulcerative Colitis

Interventions:

Recommended dose in patients with UC: 300 mg intravenously at weeks 0, 2, and 6 and every 8 weeks thereafter.

Discontinue vedolizumab at week

Date: 2022-07-25